Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology | Podiatry | Immunology | Infections and Infectious Diseases
Clinical Trials: Warts
A listing of clinical trials currently looking for volunteers to enroll in Warts studies. Click on the closest city to find more detailed information on a research study in your area.
Arkansas
Fort Smith : Johnson Dermatology Updated
Candin Safety & Efficacy Study for the Treatment of Warts
Rogers :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
California
Duarte : City of Hope Medical Center
Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors
Fremont :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Lomita :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Connecticut
New Haven : Yale School of Medicine
A Comparative Study of Occlusive Heat Patch in the Treatment of Warts
District of Columbia
Washington : Childrens National Medical Center
Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?
Washington : Georgetown University Hospital
Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?
Florida
Miami :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Illinois
Arlington Hts :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Indiana
Elwood :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Iowa
Iowa City : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Kentucky
Owensboro :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Massachusetts
Beverly :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Haverhill :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Michigan
Fort Gratiot :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
New Hampshire
Newington :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
West Portsmouth :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
New York
Rochester :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
North Carolina
Raleigh :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Salisbury :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Ohio
Columbus :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Texas
College Station :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Dallas :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Galveston : Teen Health Centers
Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers
San Antonio :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Virginia
Norfolk : Sentara Norfolk General Hospital
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
Virginia Beach :
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Washington
Wenatchee : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Brazil
Barretos : Barretos Cancer Hospital
Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas
Campinas : GSK Investigational Site
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Campinas : GSK Investigational Site
Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study
Curitiba : GSK Investigational Site
Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study
Porto Alegre : GSK Investigational Site
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
View More »
Porto Alegre : GSK Investigational Site
Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study
São Paulo : GSK Investigational Site
Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study
Canada
Edmonton : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Halifax : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Sherbrooke : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Truro : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Vancouver : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Denmark
Aalborg : Dermatology Clinic, Vesterbro
bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients
Aarhus C : Marselisborg University Hospital
bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients
Copenhagen NV : Bispebjerg University Hospital
bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients
Hellerup : Gentoftte Amtssygehus
bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients
Odense : Odense University Hospital
bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients
France
Creteil : Hopital Henri Mondor-Dept of Dermatology
Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts
Paris : SGS Aster
Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts
India
Chennai : GSK Investigational Site
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Kolkata : GSK Investigational Site
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Mumbai : GSK Investigational Site
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Pune : GSK Investigational Site
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Netherlands
Amsterdam : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Portugal
Almada : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Coimbra : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Lisboa : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Setúbal : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
South Africa
Cape Town : Groote Schuur Hospital
Female Genital Warts, Human Papilloma Virus (HPV) Typing and Burden of Disease
Taiwan
Tainan : National Cheng Kung University Hospital
SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma
Thailand
Bangkok : GSK Investigational Site
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Chiangmai : GSK Investigational Site
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
United Kingdom
Manchester : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
